Translated by: MOS Education team – Tony MG
Agence France-Presse in New York – Pfizer expects a Covid-19 vaccine targeting the Omicron variant to be ready in March, the company’s head said Monday.
Pfizer Chief Executive Officer Albert Bourla told CNBC that Pfizer is already manufacturing booster doses due to rising interest from governments, as authorities contend with huge Covid-19 infection counts, including large numbers of “breakthrough” Omicron cases in vaccinated populations.
“This vaccine will be ready in March,” Bourla told the network. “I don’t know if we will need it. I don’t know if and how it will be used”. Bourla said the existing regime of two vaccine shots and a booster has provided “reasonable” protection against serious health effects from Omicron.
But a vaccine focused directly on the highly contagious Omicron variant would also guard against breakthrough infections also resulting in many mild or asymptomatic cases.
In a separate interview with CNBC Monday, Moderna CEO Stephane Bancel said the company is developing its own booster that could address Omicron and other emerging strains expected in the fall of 2022.
“We are discussing with public health leaders around the world to decide what we think is the best strategy for a potential booster for the fall of 2022”, Bancel told the network. “We need to be careful to try to stay ahead of a virus and not behind the virus”.
We are not against vaccines, only against toxic vaccines. We are not against science, only against pseudoscience.
After a new CCP virus strain was released, people are forced to take a new shot. One shot after another which has tens of trillions of toxic spike proteins. How many shots are considered “fully vaccinated”? Right now, even the CEO of Pfizer is not confident, “I don’t know if we need it. I don’t know if and how it will be used”. His incoherent remarks reveal his obvious attempt to hide the truth and responsibility.
Proofread by: Linda Progress
Edited and Posted by: Linda Progress
More information, follow us
Disclaimer: This article only represents the author’s view. Gnews is not responsible for any legal risks.